VIKING GLOBAL INVESTORS LP 13D and 13G filings for Standard BioTools Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-20 6:05 pm Purchase | 2024-03-18 | 13G | Standard BioTools Inc. LAB | VIKING GLOBAL INVESTORS LP | 58,651,170 15.300% | 29,544,805 (+101.51%) | Filing |
| 2024-01-09 4:46 pm Purchase | 2024-01-05 | 13G | Standard BioTools Inc. LAB | VIKING GLOBAL INVESTORS LP | 29,106,365 9.500% | 20,817,249 (+251.14%) | Filing |
| 2023-11-22 4:15 pm Unchanged | 2023-10-04 | 13D | Standard BioTools Inc. LAB | VIKING GLOBAL INVESTORS LP | 8,289,116 9.500% | 0 (Unchanged) | Filing |
| 2023-10-16 4:30 pm Sale | 2023-10-04 | 13D | Standard BioTools Inc. LAB | VIKING GLOBAL INVESTORS LP | 8,289,116 9.500% | -34,705 (-0.42%) | Filing |
| 2023-02-14 1:18 pm Purchase | 2022-12-31 | 13G | Standard BioTools Inc. LAB | VIKING GLOBAL INVESTORS LP | 8,323,821 9.500% | 220,294 (+2.72%) | Filing |
| 2022-04-14 5:09 pm Purchase | 2022-04-04 | 13G | Standard BioTools Inc. LAB | VIKING GLOBAL INVESTORS LP | 8,103,527 9.500% | 8,103,527 (New Position) | Filing |